TILT Biotherapeutics
ID: 5376552TILT Biotherapeutics is a developer of gene therapies for cancer founded in 2013 by Akseli Hemminki.
3
Funding Rounds
$47.6m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ak**** He****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company TILT Biotherapeutics has raised a total of $47.6m in funding over 3 rounds.
Key Insights:
- TILT Biotherapeutics Series B Round, May 2025: $25.6m
- TILT Biotherapeutics February 2023 Series A Funding Round: $11m
- TILT Biotherapeutics December 2016 Seed Funding Round: $11m
Industries
TILT Biotherapeutics is active in the following industries: